Impact of Population Characteristics on Diagnostic Test Performance Metrics

Influence of Population Characteristics on Test Performance Metrics

Sensitivity and specificity are traditionally considered test characteristics that should remain stable regardless of disease prevalence 1
PPV and NPV are strongly influenced by the prevalence of the condition in the population being tested 1, 3, 4
PPV increases as disease prevalence increases, while NPV decreases, with the mathematical relationship expressed as: PPV ≈ [sensitivity/(1-specificity)] × prevalence 5
Even tests with excellent sensitivity and specificity can have poor PPV in populations with low disease prevalence 6

In Alzheimer's disease testing, the prevalence of amyloid pathology varies by age, severity of clinical symptoms, race/ethnicity, sex, and genetic factors 1, 3
For the same blood biomarker test, PPV and NPV vary significantly depending on whether the population has high (80%), intermediate (50%), or low (20%) clinical suspicion of Alzheimer's disease 1, 4
In C. difficile testing, the posterior probability of a positive test result (PPV) is only 50% in populations with low disease prevalence, even with high test sensitivity 7
To overcome low PPV issues in low-prevalence settings, two-step testing approaches are recommended 7
In prenatal screening for neural tube defects, the PPV for the same test ranges from 0.5% to 1% depending on population characteristics 5, 8
Race, family history, twin pregnancies, and folate status all impact the prior risk for neural tube defects, thereby affecting predictive values 5

Clinicians must consider the prevalence of disease in their specific population when interpreting test results 3, 4
Calculators that incorporate easily ascertainable parameters (age, symptoms, risk factors) can help estimate pre-test probability 1
In low-prevalence settings, positive test results should be interpreted with caution due to lower PPV 7, 6
In high-prevalence settings, negative test results should be interpreted with caution due to lower NPV 1, 3
Two-step testing approaches may be valuable in settings where false positives would lead to significant harm 7

Ignoring the impact of population characteristics like age, sex, ethnicity, and genetic factors on pre-test probability 1, 3
Using reference ranges derived from populations that differ from the local population being tested 9